Navigation Links
Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
Date:11/13/2007

y have been shown to reduce complications of the disease and enhance patients' long-term health and quality of life.

Underlying the Company's programs is a novel, proprietary manufacturing technology that allows a greater yield of high-quality protein at a significantly lower cost than is currently available. Inspiration is utilizing this technology to develop a portfolio of hemophilia and bleeding disorder products that address a $5 billion market worldwide.

Inspiration's lead product candidate, an intravenous recombinant Factor IX, has completed preclinical testing and is poised to enter Phase I/II clinical studies in the United States.


'/>"/>
SOURCE Inspiration Biopharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3

Related medicine technology :

1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
2. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
3. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
4. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
5. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...tCall/ -- BioForm Medical,Inc. (Nasdaq: BFRM ) t...Polidocanol, conducted in Germany by BioForm Medic...H (Kreussler), successfully met the study primary,...a New Drug Application,(NDA) process., In the piv...safety of,Aethoxysklerol compared to Sodium Tetrad...
(Date:9/4/2008)...ented at ESC Congress-, PHILADELPHIA, Sept. 4 /PR...y, the GISSI Heart Failure (GISSI-HF) study, showe...uced all cause mortality and hospital,admissions f... heart,failure. These findings are published in th...presented at the European Cardiovascular Society (...
(Date:9/4/2008)...outhern Research Institute,today announced that th...,the organization to participate in the newly-fund...work (MLPCN). The MLPCN -- a collaborative,researc...ogram which is,designed to benefit human health, b...d validate future targets for drug discovery., So...
(Date:9/4/2008)...e/ -- Axentis Pharma AG has,initiated a clinical p...ty,of a new therapeutic formulation for the treatm...is patients. The new formulation allows an,establi... the site of,infection. The forthcoming trial will...f the new drug. Initial results are expected in su...
Breaking Medicine Technology:338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Microchip Biotechnologies Inc Collaborating With Stanford University on Developing a Front End Microfluidic Based Sample Preparation System for Pyro 3591 1Microchip Biotechnologies Inc Collaborating With Stanford University on Developing a Front End Microfluidic Based Sample Preparation System for Pyro 3591 2Vermillion Receives Award From the Society of Gynecologic Oncologists 1441 1Vermillion Receives Award From the Society of Gynecologic Oncologists 1441 2Vermillion Receives Award From the Society of Gynecologic Oncologists 1441 3Vermillion Receives Award From the Society of Gynecologic Oncologists 1441 4Natures helpers 3A Using microorganisms to remove TCE from water 12998 1Natures helpers 3A Using microorganisms to remove TCE from water 12998 2Natures helpers 3A Using microorganisms to remove TCE from water 12998 3The Female Health Company Receives USAID DELIVER PROJECT Order for 6 1 Million Units 12995 1The Female Health Company Receives USAID DELIVER PROJECT Order for 6 1 Million Units 12995 2
... and Regulatory Development of Oral,Anti-Inflammat...ire-FirstCall/ -- Celgene,Corporation announced it... anti-inflammatory candidates across a broad range...an oral TNF,antagonist and anti-inflammatory agent...llent side effect profile in a placebo,controlled ...
...2007 /PRNewswire/ -- NanoBio,Corporation, a biopha...the treatment and prevention of serious infections...ase 1 clinical study of,NB-002, the company,s drug...or the topical treatment of onychomycosis. , The P...7 and,involved 20 subjects who received twice-dail...
Other Medicine Technology:Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 2Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 3Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 4NanoBio Corporation Announces Positive Phase 1 Clinical Results for,Topical Treatment for Onychomycosis 2NanoBio Corporation Announces Positive Phase 1 Clinical Results for,Topical Treatment for Onychomycosis 3
(Date:9/8/2008)...aser scalpels, arthroscopic,surgery, genomic resea...rinary medicine is quickly expanding into new high...e benefit; it,s improving medicine for,people, too... care for their pets to,treat diseases like diabet... according to the American Veterinary Medical Asso...
(Date:9/8/2008)...zine examines Iraq and Afghanistan veterans, strug..., Washington, DC (PRWEB) S...by veterans of the Iraq and Afghanistan wars about... addiction disorders are featured in the current i...ublication of the National Council for Community B...
(Date:9/7/2008)...f older patients successfully treated for colorect...le to detect any recurrence of cancer. The study, ... , a peer-reviewed journal of the American Cancer ...monitoring of colorectal cancer survivors could af...y curative surgery for colorectal cancer have an i...
(Date:9/7/2008)... appear to lower a man,s PSA level, the blood biom...her a man is at risk of prostate cancer. , But t.... 8 in the journal Cancer , caution that men shou... prostate cancer just yet. , "We showed that me...rin and other non-steroidal anti-inflammatory drug...
Breaking Medicine News(10 mins):Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:Helping Veterans in Our Communities 2Health News:Helping Veterans in Our Communities 3Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Common painkillers lower levels of prostate cancer biomarker 2
... but are they getting on their feet as often as th...y the hour, are we fit// enough, is a question tha...a pedometer latched on! The government has announ...eas of England will be given pedometers; these ins...
...ay face the risk of being depressed and anxious, s...h reports from North-Trondelag County from the 199... them, those with low blood pressure most frequent...ression, reported UPI wire quoting Norwegian newsp...
...ent has urged people to stay alert to the risk of ...anti-mosquito measures//, despite the current dry ...ay (January 22) that the monthly average ovitrap i...r had dropped to 2.3%, from 7.4% in November. The...
...ave unraveled a chemical correspondent of the huma...ng promises to be a harbinger of novel ways of dia...omposition of the human body. The project costing ...a. In a maiden attempt at drafting the human 'me...
Other Medicine News:
The new Nellcor N-45 Handheld Pulse Oximeter is compatible with our complete line of OxiMax Pulse Oximetry Sensors, so clinicians have the convenience of Nellcors most advanced sensor technology in a
...or's most popular handheld oximeter has been conve... and is now compatible with the entire line of inn...ehead Sensor and SoftCare Nonadhesive Sensors. The...also incorporates Nellcor's latest advanced signal...
...ellcor N395 Pulse Oximeter with Oxismart XL Advanc...ion conditions, cutting through nonspecific noise ...rate values. , ,The N395 monitor is also equi...ugh in clinician-programmable alarm sensitivity fo...
...e cornerstone of the revolutionary OxiMax® Pul...r combines Nellcor's best-in-class pulse oximetry ... motion-tolerant OxiMax N-595 Pulse Oximeter is eq...ing technology, which enables it to withstand the ...
Medicine Products: